European panel recommends Pfizer drug OK |
|
|
|
Published
:
Thu, 19 Jul 2007 23:34
|
NEW YORK (AP) - Pfizer Inc. said Thursday an advisory panel of the European Medicines Agency has recommended that its novel HIV drug Celsentri be approved for use in the European Union.Pfizer is seeking marketing approval for Celsentri from European regulators, who will weigh the opinion of the Committee for Medicinal Products for Human Use when they make a final decision in coming months.Unlike most HIV treatments currently available, Celsentri does not attack HIV directly, but instead blocks the virus from entering cells in the first place. If approved the drug would mainly be used by patients who have stopped responding to conventional HIV treatments.In April, U.S. health advisers recommended the Food and Drug Administration approve the drug, also known as maraviroc. But last month the agency stopped short of making a decision and asked Pfizer for more information about the drug.Shares of Pfizer Inc. fell 14 cents to $24.99.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
FDA seeks more info on Pfizer HIV drug 